Media and news

One year is gone and we are back in Pisa. It’s the 10^th (and 11^th) of October 2024, and the EuSoMII, is hosting its annual meeting that brings together people with different backgrounds and expertise from the world of radiology. 

Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

Bracco Diagnostics Inc. and Subtle Medical, Inc. are thrilled to announce that their collaborative AI-powered software, AiMIFY^TM, has received FDA clearance as a Class II software as a medical device (SaMD) for magnetic resonance imaging (MRI) of the brain.

Bracco Imaging is delighted to announce that Gadopiclenol (marketed as Vueway^® by Bracco) has been honored with the JFR 2024 Innovation Award in the Jury's Favorite category.

This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.

Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.

Innovative Collaboration to Enhance Ischemic Stroke Detection and Patient Care, Elevating Standards in Diagnostic Imaging.

The collaboration focuses on combining Verasonics' Vantage^®️ NXT Research Ultrasound Systems with Bracco's contrast agents to explore improved imaging performance in various research applications.

Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals.

The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai

Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28^th to March 3^rd.

Vueway^®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Re.Viva works to capture and redeploy used substances in the positive momentum of the circular economy: the Bracco Iodine Recollection Pilot

The company, founded in 1927 and today one of global leader in imaging diagnostics, joins in the select club of companies that represent the spearhead of our Made in Italy that enhance the image of Italy in the world.

Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.

The UN Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption.

We are thrilled to open the doors of our “digital house” created by our people and inhabited by our stories

Alberto Spinazzi, Bracco Chief Medical and Regulatory Officer, answers some of these questions by illustrating future trends and the importance of prevention for human health.

The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine

Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

The astounding Bracco story unfolds across archives that have been thematically divided into five sections: Family, Company, Innovation, Sustainability, and Culture.

95 grants to celebrate Bracco’s 95th Anniversary

The US shortage crisis: Bracco Imaging’s CEO statement on New York Times

A new customised nanomedicine project to fight cancer, a new therapy that includes pre-treating

They have left the war in Ukraine behind and have been welcomed in Italy by the Bracco Group in collaboration with the Town of Cesano and the local community.

Shaharzad Akbar arrived from Rome where she had provided testimony during a meeting of Italy’s Chamber of Deputies and Senate Joint Committee on Foreign Affairs.

Some of the goals in a Policy Paper drafted by the B20 Special Initiative on Women’s Empowerment.

Trieste Next Festival: Diana Bracco and Gianvito Vilé talk about scientific research and the brain drain.

The Bracco Foundation: ten years in the name of culture, science and social engagement.